This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.
Homa Dastani, PhD
Advertisement
Articles by Homa Dastani, PhD
Advertisement
Latest Updated Articles
- Cost-Sharing and Initiation of Disease-Modifying Therapy for Multiple Sclerosis
Published: August 24th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Survey Reveals Clinician Confidence Around Using AI in PA Process
3
Better Food, Better Health: Redefining Chronic Disease Care Through Nutrition
4
Value-Based Care Interventions and Management of CKD Progression
5
